Incident · Regulatory action
Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers
Quantum Surgical received FDA 510(k) clearance for its Epione robotic-assisted platform for all abdominal cancer tumor ablation treatments, expanding the indication from initial clearance to cover all abdominal cancers.
Occurred 2026-03-26 · Quantum Surgical
Machine-readable surfaces
- Markdown mirror: /incidents/regulatory-action-2026-03-26-quantum-surgical.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/incidents/f6916652-6ad6-4f34-b3cd-d8b58f40356a
- Data documentation: /data
- Query this programmatically: Deploy MCP
Sources (1)
Status history
- Active · 2026-07-08 · agent:depth
Common questions
- What happened in Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers?
- Quantum Surgical received FDA 510(k) clearance for its Epione robotic-assisted platform for all abdominal cancer tumor ablation treatments, expanding the indication from initial clearance to cover all abdominal cancers.
- When did this incident occur?
- The incident is recorded as occurring on March 26, 2026 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
- Who was involved in Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers?
- The incident is recorded as involving Quantum Surgical on the DEPLOY registry. No specific robot model is linked to this incident in the registry.
- Has anyone responded to Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers?
- No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
- What is the current status of Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers?
- This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.
Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-07-08
Verification posture
Unreviewed
Low confidence
Review state
Stable
Last reviewed 2026-07-08
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers.Deploy Watch
Track this incident.
We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.
Canonical ID f6916652-6ad6-4f34-b3cd-d8b58f40356a